Transcription of NCCN Clinical Practice Guidelines in Oncology NCCN ...
{{id}} {{{paragraph}}}
Example: bachelor of science
NCCN Clinical Practice Guidelines in Oncology NCCN ...
, 01/18/19 2019 National Comprehensive Cancer Network ( nccn ), All rights reserved. nccn Guidelines and this illustration may not be reproduced in any form without the express written permission of Clinical Practice Guidelines in Oncology ( nccn Guidelines ) genetic /Familial High-Risk Assessment: Breast and OvarianVersion January 18, 2019 ContinueContinueNCCN Guidelines Panel Disclosures Medical Oncology Cancer/Medical genetics Internal medicine Hematology/Hematology Oncology Gynecologic Oncology /Gynecology Breast surgical Oncology & Public health and preventive medicine Patient advocacy*Discussion Writing Committee Member*Mary B. Daly, MD, PhD/Chair Fox Chase Cancer Center*Robert Pilarski, MS, CGC/Vice-chair The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteMichael P.
Updates in Version 3.2019 of the NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian from Version 2.2019 include: MS-1 • The Discussion section has been updated to reflect the changes in the algorithm. NCCN Guidelines Version 3.2019 Genetic/Familial High-Risk Assessment: Breast and Ovarian
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: